MATERIALS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA
Abstract:
A TAT-FXN fusion polypeptide useful in treating subjects diagnosed with Friedrich's Ataxia, hypertrophic cardiomyopathy, or both are disclosed, as are related methods of treatment and pharmaceutical compositions.
Information query
Patent Agency Ranking
0/0